10-K annual report · filed Nov 20, 2025

MAXIMUS, INC. (MMS) FY2025 10-K Annual Report

Short answer

MAXIMUS, INC. (MMS) filed its fiscal 2025 10-K annual report with the SEC on Nov 20, 2025. It reported revenue of $5.4B (+2.4% year over year) and net income of $319M.

  • Top risk flagged: Regulatory/legal risk: U.S. federal government shutdown risk mitigated by $222.4M cash and credit facility access but exposure remains to potential payment delays

FY2025 key financial metrics · XBRL

Revenue
$5.4B
+2.4% YoY
Net income
$319M
+3.9% YoY
Operating margin
9.7%
+0.5 pp YoY
Gross margin
24.6%
+1.0 pp YoY
EPS (diluted)
$5.51
+10.4% YoY
ROE
19.1%
+2.4 pp YoY
Operating cash flow
$429M
−16.7% YoY

Source: XBRL data from the MAXIMUS, INC. (MMS) FY2025 10-K on SEC EDGAR. USD.

MAXIMUS, INC. FY2025 10-K analysis

AI summary of each section, grounded in the filing text

Business Overview

  • Core business: government program operations and management services primarily for U.S. federal, state/local, and select international agencies
  • New emphasis on divesting international assets, including sale of Australia and Korea businesses, improving Outside the U.S. segment margins despite revenue decline
  • Strategic shift: focus on organic growth in U.S. Federal Services segment, expanding clinical programs and FEMA support, while streamlining international operations
  • Backlog remains robust at $15.3B with average contract life ~5 years; U.S. Federal Services backlog ~$9.8B supporting growth outlook
  • Operating margin improvement notable in U.S. Federal Services segment, up to 15.3% from 12.2%, driven by technology initiatives and performance improvements

Risk Factors

  • Regulatory/legal risk: U.S. federal government shutdown risk mitigated by $222.4M cash and credit facility access but exposure remains to potential payment delays
  • Macroeconomic threat: Payment delays during FY2025, with Days Sales Outstanding rising to 62 days vs. 61 days in FY2024, impacting cash collections
  • Operational vulnerability: Dependence on contract renewals amid fluctuating backlog and rebid concentrations causing temporarily reduced backlog balances
  • Competitive risk: Investment of $18M in technology upgrades for federal medical disability examinations contracts to maintain competitiveness
  • Financial risk: $1.35B debt under JPMorgan Credit Agreement with financial covenants requiring leverage ratio ≤4.00 and interest coverage ratio ≥3.00, effective interest rate 5.37%

Generated from the filing text; verify against the original. How to read a 10-K

Ask about this 10-K

Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.